| |
MarketWatch
Does Reimbursement Influence Chemotherapy Treatment For Cancer Patients?
Mireille Jacobson,
A. James OMalley,
Craig C. Earle,
Juliana Pakes,
Peter Gaccione and
Joseph P. Newhouse
Before the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003, Medicare reimbursed physicians for chemotherapy drugs at rates that greatly exceeded physicians costs for those drugs. We examined the effect of physician reimbursement on chemotherapy treatment of Medicare beneficiaries older than age sixty-five with metastatic lung, breast, colorectal, or other gastrointestinal cancers between 1995 and 1998 (9,357 patients). A physicians decision to administer chemotherapy to metastatic cancer patients was not measurably affected by higher reimbursement. Providers who were more generously reimbursed, however, prescribed more-costly chemotherapy regimens to metastatic breast, colorectal, and lung cancer patients.

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Newcomer
Three Changes for Affordable Care: One Payer's Wish List
J. Oncol. Pract,
September 1, 2009;
5(5):
219 - 221.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Bach
Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs
N. Engl. J. Med.,
February 5, 2009;
360(6):
626 - 633.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. McFarlane, J. Riggins, and T. J. Smith
SPIKE$: A Six-Step Protocol for Delivering Bad News About the Cost of Medical Care
J. Clin. Oncol.,
September 1, 2008;
26(25):
4200 - 4204.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Earle, M. B. Landrum, J. M. Souza, B. A. Neville, J. C. Weeks, and J. Z. Ayanian
Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
J. Clin. Oncol.,
August 10, 2008;
26(23):
3860 - 3866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Harrington and T. J. Smith
The Role of Chemotherapy at the End of Life: "When Is Enough, Enough?"
JAMA,
June 11, 2008;
299(22):
2667 - 2678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Ramsey
How Should We Pay the Piper When He's Calling the Tune? On the Long-Term Affordability of Cancer Care in the United States
J. Clin. Oncol.,
January 10, 2007;
25(2):
175 - 179.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Meropol and K. A. Schulman
Cost of Cancer Care: Issues and Implications
J. Clin. Oncol.,
January 10, 2007;
25(2):
180 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Bach
Costs of Cancer Care: A View From the Centers for Medicare & Medicaid Services
J. Clin. Oncol.,
January 10, 2007;
25(2):
187 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Schrag and M. Hanger
Medical Oncologists' Views on Communicating With Patients About Chemotherapy Costs: A Pilot Survey
J. Clin. Oncol.,
January 10, 2007;
25(2):
233 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Comments:
Read all Comments
- Reimbursements Sway Oncologists' Drug Choices
- Gregory D. Pawelski
- Health Affairs, 15 Mar 2006
[Full text]
- Selling Cancer Chemotherapy With Concessions Creates Conflicts Of Interest For Oncologists
- Gregory D. Pawelski
- Health Affairs, 1 Aug 2007
[Full text]
|